These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 24014569)

  • 1. Successful treatment of a mycophenolate mofetil-refractory proliferative lupus nephritis with Belimumab in a 19-year-old woman.
    Fließer EE; Korsten P; Koziolek MJ; Niewold TB; Patschan D; Müller GA; Patschan SA
    Lupus; 2013 Dec; 22(14):1523-5. PubMed ID: 24014569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.
    Dooley MA; Houssiau F; Aranow C; D'Cruz DP; Askanase A; Roth DA; Zhong ZJ; Cooper S; Freimuth WW; Ginzler EM;
    Lupus; 2013 Jan; 22(1):63-72. PubMed ID: 23263865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review.
    Margiotta DPE; Basta F; Batani V; Afeltra A
    BMC Nephrol; 2018 Mar; 19(1):54. PubMed ID: 29514612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: successful treatment of membranous lupus nephritis with belimumab in an African female immigrant.
    De Scheerder MA; Boey O; Mahieu E; Vanuytsel J; Bogaert AM
    Clin Rheumatol; 2016 Jun; 35(6):1649-53. PubMed ID: 26712500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases.
    Kasitanon N; Petri M; Haas M; Magder LS; Fine DM
    Lupus; 2008 Jan; 17(1):40-5. PubMed ID: 18089682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report.
    Fontana F; Alfano G; Leonelli M; Cerami C; Ligabue G; Spinella A; Citriniti G; Manzini CU; Ferri C; Cappelli G
    BMC Nephrol; 2018 Oct; 19(1):276. PubMed ID: 30342482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mycophenolate mofetil for the treatment of lupus nephritis. The case of lupus nephritis--class IV according to WHO--treated with mycophenolate mofetil].
    Suszek D; Wielosz E; Majdan M
    Ann Acad Med Stetin; 2010; 56 Suppl 1():91-4. PubMed ID: 21365951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of lupus nephritis with mycophenolate mofetil].
    Celić D; Ilić T; Durdević-Mirković T; Mitić I; Milić B; Curić S
    Med Pregl; 2007; 60 Suppl 2():124-7. PubMed ID: 18928177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case with good response to belimumab for lupus nephritis complicated by IgG4-related disease.
    Yamamoto M; Aochi S; Suzuki C; Nakamura S; Murakami R; Ogawa Y; Takahashi H
    Lupus; 2019 May; 28(6):786-789. PubMed ID: 30917769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil.
    Joo YB; Kang YM; Kim HA; Suh CH; Kim TJ; Park YW; Lee J; Lee JH; Yoo DH; Bae SC; Lee HS; Bang SY
    Int J Rheum Dis; 2018 May; 21(5):1031-1039. PubMed ID: 29611341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.
    Lanata CM; Mahmood T; Fine DM; Petri M
    Lupus; 2010 Jul; 19(8):935-40. PubMed ID: 20388722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
    Li X; Ren H; Zhang Q; Zhang W; Wu X; Xu Y; Shen P; Chen N
    Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
    Choi CB; Won S; Bae SC
    Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
    Staveri C; Karokis D; Liossis SC
    Semin Arthritis Rheum; 2017 Jun; 46(6):788-790. PubMed ID: 27793432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of lupus nephritis with mycophenolate mofetil].
    Celić D; Ilić T; Durdević-Mirković T; Mitić I; Milić B; Curić S
    Med Pregl; 2008; 61(5-6):270-3. PubMed ID: 19102074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
    Wang J; Hu W; Xie H; Zhang H; Chen H; Zeng C; Liu Z; Li L
    Lupus; 2007; 16(9):707-12. PubMed ID: 17728363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy.
    Karim MY; Pisoni CN; Ferro L; Tungekar MF; Abbs IC; D'Cruz DP; Khamashta MA; Hughes GR
    Rheumatology (Oxford); 2005 Oct; 44(10):1317-21. PubMed ID: 16049051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Good outcomes with mycophenolate-cyclosporine-based induction protocol in children with severe proliferative lupus nephritis.
    Aragon E; Chan YH; Ng KH; Lau YW; Tan PH; Yap HK
    Lupus; 2010 Jul; 19(8):965-73. PubMed ID: 20581019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of belimumab in three cases of refractory lupus nephritis.
    Malaweera A; Dayan S; Pellicano R; Hoi A; Kitching AR; Kent JR
    Intern Med J; 2023 Oct; 53(10):1901-1906. PubMed ID: 37859540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis.
    Radhakrishnan J; Moutzouris DA; Ginzler EM; Solomons N; Siempos II; Appel GB
    Kidney Int; 2010 Jan; 77(2):152-60. PubMed ID: 19890271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.